References
1. Böger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 2003; 59 (4): 824-33.
2. İlicin G, Ünal S, Biberoğlu K, et al. İç Hastalıkları cilt 2 2. Baskı Ankara: Güneş Kitapevi ISBN. 2010: 975-8531.
3. Sugimoto M, Yamaoka Y. Review of Helicobacter pylori infection and chronic renal failure. Therapeutic Ther Apher Dial. 2011; 15 (1): 1-9.
4. Romagnani P, Remuzzi G, Glassock R, et al. J. Chronic kidney disease. Nat Rev Dis Primers. 2017; 3(1): 1-24.
5. Özcan O, Erdal H, Çakırca G, et al. Oksidatif stres ve hücre içi lipit, protein ve DNA yapıları üzerine etkileri. J Clin Exp Invest. 2015; 6(3) : 331-6.
6. Liakopoulos V, Roumeliotis S, Gorny X, et al. Oxidative stress in hemodialysis patients: a review of the literature. Oxid Med Cell Longev. 2017;2017.
7. Modaresi A, Nafar M, Sahraei Z. Oxidative stress in chronic kidney disease. Iran J Kidney Dis. 2015; 9(3) :165.
8. Putri AY, Thaha M. Role of oxidative stress on chronic kidney disease progression. Acta Med Indones. 2016; 46 (3).
9. Ates I, Ozkayar N, Inan B, et al. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. J Am Soc Hypertens. 2016;10(2):159-66.
10. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem.2014;47(18):326-32
11. Arner ES, Holmgren A, editors. The thioredoxin system in cancer. Seminars in cancer biology; 2006: Elsevier
12. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem. 1989;264(24):13963-6.
13. Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem. 2001;268(1):42-7.
14. Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. An Introduction to a Special Issue of Free Radical Biology and Medicine - ”Reactive Oxygen Species and Musculoskeletal Aging”. McArdle A, Jackson MJ. Free Radic Biol Med. 2013;65:244-53.
15. Ayar G, Sahin S, Yazici MU, et al. US. Effects of Hemodialysis on Thiol-Disulphide Homeostasis in Critically Ill Pediatric Patients with Acute Kidney Injury. BioMed Research international. 2018;2018 .
16. Otal Y, Dermican S, Sener A, et al. Acute renal failure and thiol-disulfide homeostasis. J Nephrol Ther. 2018;8:312.
17. Coşkun C, Emre HÖ, Gümüş A et al. S. Diyabetik ve Diyabetik Olmayan Kronik Böbrek Yetmezliğinde Dinamik Tiyol Disülfit Homeostazı ve İleri Protein Oksidasyon Ürünleri (AOPPs). Deneysel Tıp Araştırma Enstitüsü Dergisi.6(12):1-9.
18. Ateş İ, Özkayar N, Yılmaz FM, et al. Oxidative stress level in patients with chronic kidney disease. Ortadogu Medical Journal/Ortadogu Tip Dergisi. 2018;10(1).
19. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1-12.
20. Carballal S, Alvarez B, Turell L, et al. Sulfenic acid in human serum albumin. Amino acids.2007;32(4):543-51.
21. Carbonell LF, Nadal JA, Llanos MC, et al. Depletion of liver glutathione potentiates the oxidative stress and decreases nitric oxide synthesis in a rat endotoxin shock model. Crit Care Med. 2000;28(6):2002-6.
22. Fanti P, Giustarini D, Rossi R, et al. Dietary intake of proteins and calories is inversely associated with the oxidation state of plasma thiols in end-stage renal disease patients. J Ren Nutr. 2015;25(6):494-503.
23. Simons Zuwała-Jagiełło J, Warwas M, Pazgan-Simon M. Ischemia-modified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation. Acta Biochim Pol. 2012;59(4).
24. Reddy CB, Cyriac C, Desle HB. Role of “Ischemia Modified Albumin”(IMA) in acute coronary syndromes. Indian Heart J. 2014;66(6):656-62.
25. Turedi S, Cinar O, Yavuz I et al. Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population. J Nephrol.2010;23(3):335-40.